Hamdard Labs to start clinical trial of two immunity boosting drugs for COVID-19

The company has received all the regulatory approvals to begin the proof of concept clinical trial for its Infuza and Kulzam drugs, Hamdard Laboratories said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32YulW4
via IFTTT